Skip to Content

Finally! Actionable Genomic Insights Where it Matters… at the Point of Care

  • 2bPrecise Launches a Genomics and Precision Medicine Initiative At NIH

    Leading physicians in genomic medicine to use the 2bPrecise clinical-genomic solution to improve patient diagnosis, advance medical research

    READ MORE
  • HMG Selects 2bPrecise

    2bPrecise, an Allscripts company, partners with Holston Medical Group to launch early adopter genomics and precision medicine initiative

    READ MORE

It’s a new world The Power of Precision Medicine, Now at the Point of Care

Precision medicine can empower providers to apply genomic insights within their clinical practice to save lives, improve outcomes and reduce costs. The technology and know-how are available today to put the power of precision medicine into the hands of physicians, and extend actionable genomic understanding beyond the walls of research, to allow all providers to more precisely diagnose and effectively treat their patients.

The 2bPrecise platform stores raw and interpreted genomic information in a robust data model, establishes a semantic ontology to correlate it with actual patient-specific and population-level clinical data, and inserts relevant, understandable and actionable genomic insights within an EHR-agnostic workflow.

To do this, we had to solve 3 problems:


  • CAPTURE

    A meaningful genomic data repository is the foundation.
    Genetic and genomic data often resides in multiple isolated silos managed by scientists and labs, and interpretation data is frequently faxed or delivered to clinicians via PDF. Providers struggle to find a home for this incredibly valuable information to make it available, meaningful and actionable to clinicians and researchers.


  • ANALYZE

    Moving from readable to actionable is core to enabling true precision medicine. Data must be stored within a model that allows for the discrete identification of interpretation variants and annotations within a specific patient’s clinical context. Accurately merging and extracting the meaningful elements from combined phenotypic (clinical), genetic, and genomic data is extraordinarily complex and difficult and goes well beyond limiting Phenotypic-Genotypic registries available online today. Creating a rich symantic ontology to store and harmonize these data sets is the foundation to deriving actionable patient-specific insights.


  • ENGAGE

    Presenting relevant and accurate data to clinicians within their workflow is the last mile to meaningful utilization. Today, clinicians work in a variety of EHR systems, and they often receive genetic and genomic test results in the unique language of genetic science and outside of their clinical workflow as non-discrete documents.

Why Precision Medicine Has The Spotlight

  • Providers

    Genomic testing in a subgroup of patients suffering from cardiac disease, resulted in a 30% reduction in hospital admissions.1

  • Payers

    $25 billion annual spending on genetic tests
    by 2021.2 45% of FDA approvals were
    geared toward targeted therapies in 2013.3

  • Patients

    9 out of 10 causes of death are
    influenced by genetics.4

  • Pharma

    $7.5 billion will be the size of the
    pharmacogenomics market by 2017.5

  • Government

    $215 million: President Obama’s
    precision medicine initiative investment.6